NASDAQ:LMAT - LeMaitre Vascular Stock Price, Forecast & News

LeMaitre Vascular trades on the NASDAQ under the ticker symbol "LMAT."

LeMaitre Vascular declared a quarterly dividend on Monday, October 21st. Shareholders of record on Wednesday, November 20th will be paid a dividend of $0.085 per share on Thursday, December 5th. This represents a $0.34 annualized dividend and a dividend yield of 0.96%. The ex-dividend date is Tuesday, November 19th. View LeMaitre Vascular's Dividend History.

LeMaitre Vascular Inc (NASDAQ:LMAT) posted its earnings results on Wednesday, October, 23rd. The medical instruments supplier reported $0.25 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.21 by $0.04. The medical instruments supplier had revenue of $29.10 million for the quarter, compared to the consensus estimate of $28.15 million. LeMaitre Vascular had a net margin of 16.76% and a return on equity of 13.38%. The company's revenue was up 20.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.21 EPS. View LeMaitre Vascular's Earnings History.

LeMaitre Vascular is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for LeMaitre Vascular.

LeMaitre Vascular issued an update on its FY19 earnings guidance on Wednesday, October, 23rd. The company provided earnings per share (EPS) guidance of $0.88-0.90 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.85. The company issued revenue guidance of $117.2-118.0 million, compared to the consensus revenue estimate of $116.17 million.

4 analysts have issued 1 year price objectives for LeMaitre Vascular's shares. Their forecasts range from $37.00 to $40.00. On average, they expect LeMaitre Vascular's share price to reach $39.00 in the next twelve months. This suggests a possible upside of 9.6% from the stock's current price. View Analyst Price Targets for LeMaitre Vascular.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for LeMaitre Vascular in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for LeMaitre Vascular.

News coverage about LMAT stock has trended negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. LeMaitre Vascular earned a daily sentiment score of -2.7 on InfoTrie's scale. They also gave press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for LeMaitre Vascular.

LeMaitre Vascular saw a increase in short interest in the month of November. As of November 29th, there was short interest totalling 1,990,000 shares, an increase of 10.6% from the November 14th total of 1,800,000 shares. Based on an average daily volume of 125,600 shares, the days-to-cover ratio is currently 15.8 days. Currently, 12.1% of the shares of the company are sold short. View LeMaitre Vascular's Current Options Chain.

Some companies that are related to LeMaitre Vascular include Glaukos (GKOS), Inspire Medical Systems (INSP), Merit Medical Systems (MMSI), Irhythm Technologies (IRTC), Cardiovascular Systems (CSII), Atrion (ATRI), Tactile Systems Technology (TCMD), Shockwave Medical (SWAV), AtriCure (ATRC), Silk Road Medical (SILK), Cryolife (CRY), Luminex (LMNX), Orthofix Medical (OFIX), MiMedx Group (MDXG) and Antares Pharma (ATRS).

Based on aggregate information from My MarketBeat watchlists, some companies that other LeMaitre Vascular investors own include Canopy Growth (CGC), Sociedad Quimica y Minera de Chile (SQM), Aurora Cannabis (ACBFF), NVIDIA (NVDA), AbbVie (ABBV), Gilead Sciences (GILD), Aurora Cannabis (ACB), Adobe (ADBE), salesforce.com (CRM) and Teva Pharmaceutical Industries (TEVA).

LeMaitre Vascular's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (8.68%), State Street Corp (3.09%), Copeland Capital Management LLC (2.70%), Russell Investments Group Ltd. (1.82%), Summit Creek Advisors LLC (1.54%) and Rhumbline Advisers (0.76%). Company insiders that own LeMaitre Vascular stock include David B Roberts, George W Lemaitre, Joseph P Pellegrino Jr, Lawrence J Jasinski, Michael H Thomas and Trent G Kamke. View Institutional Ownership Trends for LeMaitre Vascular.

LMAT stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Conestoga Capital Advisors LLC, GW&K Investment Management LLC, Barclays PLC, Rice Hall James & Associates LLC, Curbstone Financial Management Corp and Commonwealth Equity Services LLC. Company insiders that have sold LeMaitre Vascular company stock in the last year include David B Roberts, George W Lemaitre, Joseph P Pellegrino Jr, Lawrence J Jasinski, Michael H Thomas and Trent G Kamke. View Insider Buying and Selling for LeMaitre Vascular.

LMAT stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Copeland Capital Management LLC, Summit Creek Advisors LLC, Rhumbline Advisers, Comerica Bank, Envestnet Asset Management Inc., Bridge City Capital LLC and Voya Investment Management LLC. View Insider Buying and Selling for LeMaitre Vascular.

Shares of LMAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of LMAT stock can currently be purchased for approximately $35.58.

LeMaitre Vascular has a market capitalization of $711.24 million and generates $105.57 million in revenue each year. The medical instruments supplier earns $22.94 million in net income (profit) each year or $0.84 on an earnings per share basis. View Additional Information About LeMaitre Vascular.

The official website for LeMaitre Vascular is http://www.lemaitre.com/.

LeMaitre Vascular's mailing address is 63 SECOND AVENUE, BURLINGTON MA, 01803. The medical instruments supplier can be reached via phone at 781-221-2266.